Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resection
Open Access
- 24 June 2024
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 11 (8) , 2176-2187
Abstract
Objective: The molecular era of glioma diagnosis and treatment has arrived, and a single rapid histopathology is no longer sufficient for surgery. This study sought to present an automatic integrated gene detection system (AIGS), which enables rapid intraoperative detection of IDH/TERTp mutations.Methods: A total of 78 patients with gliomas were included in this study. IDH/TERTp mutations were detected intraoperatively using AIGS in 41 of these patients, and they were guided to surgical resection (AIGS detection group). The remaining 37 underwent histopathology‐guided conventional surgical resection (non‐AIGS detection group). The clinical utility of this technique was evaluated by comparing the accuracy of glioma subtype diagnosis before and after TERTp mutation results were obtained by pathologists and the extent of resection (EOR) and patient prognosis for molecular pathology‐guided glioma surgery.Results: With NGS/Sanger sequencing and chromosome detection as the gold standard, the accuracy of AIGS results was 100%. And the timing was well matched to the intraoperative rapid pathology report. After obtaining the TERTp mutation detection results, the accuracy of the glioma subtype diagnosis made by the pathologists increased by 19.51%. Molecular pathology‐guided surgical resection of gliomas significantly increased EOR (99.06% vs. 93.73%, p < 0.0001) and also improved median OS (26.77 vs. 13.47 months, p = 0.0289) and median PFS (15.90 vs. 10.57 months, p = 0.0181) in patients with glioblastoma.Interpretation: Using AIGS intraoperatively to detect IDH/TERTp mutations to accurately diagnose glioma subtypes can help achieve maximum safe resection of gliomas, which in turn improves the survival prognosis of patients.Keywords
This publication has 51 references indexed in Scilit:
- Conventional and emerging treatments of astrocytomas and oligodendrogliomasJournal of Neuro-Oncology, 2022
- High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRIJournal of Neuro-Oncology, 2022
- Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomasEuropean Journal of Cancer, 2020
- State-of-the-art imaging for glioma surgeryNeurosurgical Review, 2020
- Evaluation of pediatric glioma outcomes using intraoperative MRI: a multicenter cohort studyJournal of Neuro-Oncology, 2019
- Visualization technologies for 5-ALA-based fluorescence-guided surgeriesJournal of Neuro-Oncology, 2018
- A novel all-in-one intraoperative genotyping system for IDH1-mutant gliomaBrain Tumor Pathology, 2017
- Association of the Extent of Resection With Survival in GlioblastomaJAMA Oncology, 2016
- Maximizing safe resection of low- and high-grade gliomaJournal of Neuro-Oncology, 2016
- Rapid Intraoperative Molecular Characterization of GliomaJAMA Oncology, 2015